Nimotuzumab Injection is whole antibody which is known to work by binding to growth factor receptor and inhibiting cancer cell proliferation. It is said to have high specificity to extracellular region of EPGFR which causes blocking of ligand binding & receptor activation. This injection is administered via intravenous route by trained professional. It is highly effective in nature and assures targeted mode of action. Nimotuzumab Injection is available at competitive rates in bulk for our trusted clients. It is a humanized antibody which shows elimination half life of about 62 to 304 hours.
Cash in Advance (CID), Cash Advance (CA)
500 Per Month
Main Export Market(s)
Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
Main Domestic Market
Other Products in 'Pharmaceutical Injection' You May Like